Prescription Monitoring Program (PMP) Public Use Data

Washington’s PMP was created (RCW 70.225 (2007)) to improve patient care and prevent harmful effects with using controlled substance prescription drugs by collecting dispensing records for Schedule II, III, IV and V drugs, and by making the information available to medical providers and pharmacists as a patient care tool. Program rules, WAC 246-470, took effect August 27, 2011. The program started data collection from all dispensers October 7, 2011. This public data only includes dispensations starting from January 1, 2012 to the latest data available.

Under RCW 70.225.040(5)(a), the department is authorized to publish public data after removing information that could be used directly or indirectly to identify individual patients, requestors, dispensers, prescribers, and persons who received prescriptions from dispensers. The data available here are de-identified, and exclude patient, prescriber, and dispenser related information in alignment with program rules WAC 246-470-080. No requestor information is available here.

Prescriptions excluded from the PMP include those dispensed outside of WA State, those prescribed for less than or equal to 24 hours, those administered or given to a patient in the hospital, and those dispensed from a Department of Corrections pharmacy (unless an offender is released with a prescription), an Opioid Treatment Program, and some federally operated pharmacies (Indian Health Services and Veterans Affairs report voluntarily since 2015).

Further information on collection and management of PMP data at DOH can be found at https://doh.wa.gov/public-health-provider-resources/healthcare-professions-and-facilities/prescription-monitoring-program-pmp/data.

Data and Resources

Additional Info

Field Value
Source https://data.wa.gov/resource/8y5c-ekcc
Author WA PMP
Last Updated July 31, 2026, 14:06 (UTC)
Created July 22, 2025, 20:22 (UTC)
1. Prescription drug information is based on dispenser-reported NDCs and supplemented with an internal drug file derived from sources such as the FDA NDC Directory, CDC opioid MME conversion files, and RxNorm. When available, RxNorm standardizes drug names and classifications and links them across commonly used drug vocabularies, including USP nomenclature. Beginning January 1, 2018, prescription records include 26 additional variables unavailable in earlier years. Tramadol became a Schedule IV drug in August 2014, and hydrocodone was rescheduled from Schedule III to Schedule II in October 2014.
2. This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product. For more information about RxNorm, please see: Nelson SJ, Zeng K, Kilbourne J, Powell T, Moore R. Normalized names for clinical drugs: RxNorm at 6 years. J Am Med Inform Assoc. 2011 Jul-Aug;18(4)441-8. doi: 10.1136/amiajnl-2011-000116. Epub 2011 Apr 21. PubMed PMID: 21515544; PubMed Central PMCID: PMC3128404.
3. Records from 2012 Q1–2025 Q2 were updated for completeness and may not be comparable with earlier dataset versions. MME conversion factors align with the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain. Records from 2012 Q1–2025 Q2 were revised to correct animal and non-human classification flags. Affected fields include species, human, animal, and prescriberVet. Revised values may not be comparable with earlier dataset versions.
Category health
Period of Time 2012Q1-2026Q1 (January 1, 2012 - March 31, 2026)
Posting Frequency Quarterly
harvest_object_id 73fccff4-4009-4289-ae6c-e6c9836670d8
harvest_source_id c4128faf-39ff-4aa3-918e-8a395702cab3
harvest_source_title washington-state